Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSGeneric

IDARUBICIN HYDROCHLORIDE

IDARUBICIN HYDROCHLORIDE

Standard Dose
5MG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview IDARUBICIN HYDROCHLORIDE is listed in Drugs@FDA under application 065037 (ANDA).

Marketing status: Discontinued Active ingredient IDARUBICIN HYDROCHLORIDE Form and strength POWDER;INTRAVENOUS - 5MG/VIAL Sponsor TEVA PARENTERAL Submission history Latest submission status date: 2002-05-01 00:00:00.

Structured Monograph

Clinical summary

Approval overview IDARUBICIN HYDROCHLORIDE is listed in Drugs@FDA under application 065037 (ANDA). Marketing status: Discontinued Active ingredient IDARUBICIN HYDROCHLORIDE Form and strength POWDER;INTRAVENOUS - 5MG/VIAL Sponsor TEVA PARENTERAL Submission history Latest submission status date: 2002-05-01 00:00:00. Submission type: ORIG.

Monitoring

  • • Review priority: STANDARD
  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.